Daratumumab，克拉霉素，泊马度胺和地塞米松(D-ClaPd)在先前暴露于Daratumumab的多发性骨髓瘤患者中的II期研究

{"title":"Daratumumab，克拉霉素，泊马度胺和地塞米松(D-ClaPd)在先前暴露于Daratumumab的多发性骨髓瘤患者中的II期研究","authors":"","doi":"10.31525/ct1-nct04302324","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9602,"journal":{"name":"Case Medical Research","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab\",\"authors\":\"\",\"doi\":\"10.31525/ct1-nct04302324\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9602,\"journal\":{\"name\":\"Case Medical Research\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31525/ct1-nct04302324\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31525/ct1-nct04302324","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}